Skip to content
healthcare.dev

Thiotepa

NDC 65219-029, Thiotepa, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.

Product NDC
65219-029
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214222
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • THIOTEPA100 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
65219-029-20652190029201 VIAL in 1 CARTON (65219-029-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/493410f3-0733-4f76-8050-6529d96f2a5b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65219-029

Use it

Look up 65219-029 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.